Legal Representation
Attorney
Dyan M. House
USPTO Deadlines
Application History
28 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 18, 2020 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| Jun 18, 2020 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Dec 6, 2019 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Dec 6, 2019 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Dec 6, 2019 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Nov 6, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Nov 6, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Nov 2, 2019 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Oct 31, 2019 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | Loading... |
| Oct 26, 2019 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Oct 26, 2019 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
| Oct 26, 2019 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Sep 20, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Sep 19, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 19, 2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 19, 2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Mar 19, 2019 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 19, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 4, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Mar 4, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 27, 2019 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Feb 22, 2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Aug 22, 2018 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Aug 22, 2018 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Aug 22, 2018 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Aug 13, 2018 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 2, 2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jun 30, 2018 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical products for ophthalmological use; pharmaceutical products for cardiovascular use; pharmaceutical preparations in the field of ophthalmology; pharmaceutical preparations in the field of cardiology; pharmaceuticals in the field of ophthalmology; pharmaceuticals in the field of cardiology; pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents
First Use Anywhere:
0
First Use in Commerce:
0
Class 010
Medical and surgical apparatus for use in general surgery; medical devices for the treatment of ophthalmological diseases and conditions; medical devices for the treatment of cardiovascular diseases and conditions; drug delivery systems
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Pharmaceutical research and development; pharmaceutical drug development services; consulting services in the field of pharmaceuticals and biotechnology research and development; conducting research and clinical trials relating to medical devices and pharmaceuticals in the field of ophthalmology; conducting research and clinical trials relating to medical devices and pharmaceuticals in the field of cardiology; development of pharmaceutical preparations and medicines; testing of pharmaceuticals
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005
010
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"THERAPEUTICS"